New data includes real-world analyses of VOQUEZNA-treated patients in the U.S. diagnosed with gastroesophageal reflux disease (GERD) FLORHAM PARK, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Phathom ...

Sebela Pharma announces positive results from phase 3 TRIUMpH programme of tegoprazan in GERD: Braintree, Massachusetts Friday, April 25, 2025, 18:00 Hrs [IST] Braintree Laborator ...

“Tegoprazan offers an exciting new treatment option for individuals suffering from GERD, helping to address the substantial unmet need of patients not well-controlled by conventional PPI therapy,” ...

Gastroesophageal reflux disease (GERD), also known as gastro oesophageal reflux disease, is more than just the occasional ...

Results from the dual Phase III TRIUMpH trials demonstrated the statistical superiority of tegoprazan over lansoprazole in ...

Braintree Laboratories, a part of Sebela Pharmaceuticals® and a leading manufacturer of gastroenterology pharmaceutical products, today announced positive topline results from two pivotal US Phase 3 ...

When Phathom Pharmaceuticals launched its first direct-to-consumer ads for Voquezn | In a commercial debuting Monday, Kenan ...

Eosinophilic esophagitis (EoE) is a long-term immune system disease that causes inflammation to your esophagus, the tube that connects your mouth and stomach. Scientists think this may happen when ...

Eosinophilic esophagitis (EoE) is a rare inflammatory disease of the esophagus, the tube that connects your mouth to your stomach. If you have EoE, a type of white blood cell known as an ...

Kirti Ganorkar, chief executive – India Business, Sun Pharma, said: "Erosive esophagitis is a serious condition that greatly affects patients' quality of life. Despite available treatments, there ...

Sun Pharmaceutical Industries on Monday said it has introduced a medication for the treatment of Erosive Esophagitis of all grades. The Mumbai-based drug major, in a statement, said it has launched ...